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Effect of dialysate temperature on central hemodynamics and urea
kinetics. Use of cool dialysate is associated with increased intradialytic
blood pressure, but the hemodynamic mechanism is unknown. Whether
changes in dialysate temperature affect muscle blood flow, which may the
alter the degree of urea compartmentalization, also is unknown. We
measured hemodynamics and blood and dialysate-side urea kinetic indices
in nine hemodialysis patients during two cool (35.0°C) versus two warm
(37.5°C) dialysate treatments. The % change in mean arterial pressure was
different when using the cool (+6.5 9.7mmHg) versus the warm (—13.4
3.6) dialysate (P < 0.01), despite comparable amounts of fluid removal.
Percent changes in cardiac output were similar with the two dialysates, and
thus the blood pressure effect was due primarily to changes in total
peripheral resistance (%ATPR, cool +26 13.6, warm +8.6 14.5; p C
0.02). During cool dialysate use tympanic membrane temperature changed
by —0.51 0.23°C, whereas body temperature increased by 0.52 0.14°C
during use of warm dialysate. Measured urea recovery normalized to the
predialysis urea nitrogen concentration was similar with the two treat-
ments: cool 31.3 0.039 liter3; warm 29.7 0.021; P = NS. In a second
study, post-dialysis urea rebound values from 15 seconds to 30 minutes,
expressed as the percent of the post-dialysis SUN, were similar after the
two treatments: cool 11.79 + 1.4; warm 12.21 2.27, P = NS. The results
suggest that increased blood pressure associated with use of cool dialysate
is due to an increased TPR, and that this alteration in hemodynamics has
no clinically important effects on either the amount of urea removal or the
extent of post-dialysis urea rebound.
One maneuver designed to help prevent hypotension in dialysis
patients is the use of a cool dialysis solution. A number of studies
have shown that use of cool dialysate results in higher blood
pressure and in fewer hypotensive episodes [1—8]. The hemody-
namic mechanism whereby blood pressure is maintained with cool
dialysate has not been completely defined. In a dog model,
increased blood pressure associated with a cooled extracorporeal
circuit is clearly due to increased total peripheral resistance [3].
Levy et al found increased cardiac contractility with cool dialysate,
but cardiac output was not described [9]. Jost and colleagues
found that calf muscle vascular resistance increased more with
cool dialysate than with warm dialysate [8], and that use of cool
dialysate also resulted in a larger increase in plasma norepineph-
rine levels on standing after dialysis. However, central hemody-
namic changes during cool dialysate use have not been reported.
It now is well established that a single-pool model is not
adequate for describing urea kinetics during hemodialysis [10—
12], particularly with high efficiency dialysis [13] and in pediatric
dialysis [14]. What remains a point of controversy is the site of
urea sequestration. One approach, derived from pharmacokinet-
ics, holds that the principal site of urea sequestration is the
intracellular space [10, 11]. Others have emphasized the role of
tissue perfusion [15—17], and a formal regional blood flow model
of urea kinetics based on physiologically derived organ water
content and blood flow values has been described [18, 19]. One
expected corollary of the regional blood flow model is that urea
removal may be impaired when blood flow is reduced to organs
such as muscle, where most of the urea is located [18, 19].
Reduced blood flow to muscle may occur after baroreceptor-
mediated increases in vascular resistance, as in response to
hypovolemic stress [20] or with increased vascular resistance
associated with erythropoietin therapy [21, 22].
If the higher MAP seen with cool dialysate use is associated
with reduced perfusion of muscle, then one might expect the
degree of urea compartmentalization to be increased. In this case,
use of cool dialysate should be associated with a greater degree of
post-dialysis urea rebound and a reduced amount of urea re-
moval. On the other hand, a higher MAP during cool dialysis
might conceivably be associated with no change in muscle blood
flow, because cold stress affects primarily blood flow to the skin.
The total body water content, and hence urea content, of the skin
is not nearly as great as that of muscle [19], and hence changes in
skin blood flow alone should have little impact on urea compart-
mentalization. A third possibility is that use of cool dialysate may
be associated with relatively increased flow to muscle due to
better maintenance of systemic blood pressure and lack of barore-
ceptor-mediated vasoconstriction. If such were the case, the
degree of urea compartmentalixation might even be reduced with
use of cool dialysate.
To evaluate the effects of dialysis solution temperature on
central hemodynamics and urea compartmentalization, we mea-
sured blood pressure and cardiac output, and compared several
indices of urea removal in patients as they were dialyzed with
either a cool (35.0°C) or a warm (37.5°C) dialysis solution.
Methods
Nine patients were studied using a crossover design. The mean
age was 63 2.2 years. The mean post-dialysis weight was 75
5.6 kg. Three patients were diabetic. Patients were not selected
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based on hemodynamic instability. The patients underwent two
separate studies, each involving two dialysis sessions (1 using cool
and 1 using warm dialysate). One study focused on measurement
of central hemodynamics (during which dialysate urea recovery
also was measured) and the other focused on blood and dialysate
measures of urea removal.
Hemodynamic study
Each patient was dialyzed twice, once using cool and once using
warm dialysis solution. The two treatments were given on different
days and the order of the treatments was randomized. The
patients were blinded as to the nature of the treatment, although
patients often were able to detect the coolness of the dialysate. All
patients were dialyzed using Fresenius F-8 dialyzers and bicarbon-
ate dialysate at a flow rate of 500 ml/min. The dialysis session
length was always four hours. The average blood flow rate was 309
3.3 SEM ml/min. Fresenius 2008 machines were used (which
monitor the dialysate outflow), and the dialysate temperature was
set at the desired level according to manufacturer's guidelines.
Measurement of dialysate temperature by thermometer con-
firmed that dialysate of either 37.5 or 35.0°C was, in fact, being
delivered.
Blood pressure and heart rate were measured every hour during
dialysis. Cardiac output also was measured at hourly intervals
using the NCCOM3-R7 thoracic electric bioimpedance device
from Bomed, Inc. (Irvine, CA, USA). We previously have used
this device to measure cardiac output during dialysis in an
evaluation of different dialysate bases [231 and also to evaluate the
hemodynamic effects of food ingestion during dialysis [241. Heart
rate was also measured. Mean arterial pressure (MAP) was
computed as the diastolic blood pressure plus 1/3 of the pulse
pressure. Total peripheral resistance (TPR) was estimated as the
MAP divided by the cardiac index (cardiac output normalized to
anthropometrically estimated body surface area). Tympanic mem-
brane temperature was measured hourly during dialysis as well.
Serum urea nitrogen concentration was measured pre- and
post-dialysis. Total spent dialysate was collected in a large tank
containing sufficient acetic acid to neutralize all of the dialysate
bicarbonate. The purpose of this maneuver was to keep the spent
dialysate acidic, in order to limit the action of any urea-splitting
organisms which may have been present in the dialysis machine
drain tubing. At the conclusion of dialysis the entire tank was
weighed, and three separate aliquots were taken after mixing to
determine its urea concentration.
Urea kinetic study
In this study the patients underwent dialysis with cool and warm
dialysis solution, but the only hemodynamic index measured was
the blood pressure. Blood-sided urea removal measurements
included sampling of serum urea nitrogen concentration predialy-
sis, at 30, 30.25, 32, 60, and 90 minutes into dialysis, at the end of
dialysis, and at 15 seconds and 2, 10, 20, and 30 minutes
post-dialysis. At 30 minutes into dialysis, access recirculation and
dialyzer clearance were quantified. At full blood flow the dialyzer
inflow and outflow blood was sampled. Then the blood pump was
reduced to 50 ml/min, and a third sample was drawn, with the
draw beginning 15 seconds after having slowed the blood flow rate
(this is based on a 10 ml volume between the inflow dialysis needle
and sampling port). Dialysate-based indices of urea recovery
again included total collection of spent dialysate as described
above. Also, the Biostat-1000 device manufactured by Baxter
Healthcare, Inc. (Deerfield, IL, USA) was used as a third measure
of urea removal [251. This device intermittently analyzes the urea
concentration of the effluent dialysate. The Biostat creates a
biexponential fit to the dialysate curve, and from this computes
the intercompartmental urea clearance (Kc). Based on the initial
blood urea level, which is estimated by equilibration with the
blood at the outset of dialysis, the urea recovery, which is
estimated from the intermittent measurements, and the Kc, the
equilibrated postdialysis SUN is estimated and an effective Kt/V is
calculated.
Laboratory measurements
Samples for urea were centrifuged, and the serum was sepa-
rated and stored at —80°C until analysis. Urea was quantified by
converting to ammonia with urease and then assaying product
concentrations of the Berthelot reaction (Sigma Inc., St. Louis,
MO, USA) [261. All samples were assayed in triplicate, and
separate standards were used for dialysate. The possible con-
founding effects of acetic acid added to the dialysate on the
Berthelot assay were tested for using appropriate in vitro standard
curves and were found to be absent. The coefficient of variation
for the method was 3 to 4%.
Post-dialysis urea rebound between 15 seconds and 30 minutes
was computed by two methods. In one method, rebound was
expressed as percent increase above the 15 second post-concen-
tration. In another method, rebound was computed as a fraction
of the decrease in SUN during dialysis [100 X (rebound value —
15 seconds post-valuel/(pre-value — 15 seconds post-value). Re-
bound at 30 minutes was corrected for urea generation in these
calculations. Total grams of urea removed in the dialysate were
obtained from the Biostat-1000 output, and also were calculated
from the average urea concentration of the samples taken from
the tank containing the total volume of spent dialysate. To correct
for variations in predialysis SUN between the two treatments, the
number of grams of urea removed per treatment was normalized
by dividing by the predialysis SUN level.
Results
Hemodynamic study
Initial hemodynamic conditions were similar prior to the two
treatments: MAP cool: 110 4.0 mm Hg, warm: 105 4.0, P =
NS; Cardiac index cool: 3.14 1.3 liter/min/M2, warm 3.42 2.5,
P = NS, heart rate cool: 79 2.0 beats/mm, warm: 81 3.2, P =
NS. Initial tympanic membrane temperatures also were similar:
cool 35.7 0.22°C, warm 35.6 0.17°C, P = NS.
All patients tolerated both treatments well, without hypoten-
sion of a degree sufficient to warrant intervention. The ultrafiltra-
tion volume (liters) was similar for the two treatments: cool 2.76
0.37; warm 2.87 0.55, P = NS. However, during the cool
dialysate treatments, mean arterial pressure was significantly
higher than during the warm treatments (%MAP cool +6.5
9.7 mm Hg, warm: —13.4 3.6, P < 0.01). The percent changes
in cardiac output were similar with the two dialysates (cool —14.0
3.1%, warm —13.6 6.9, P = NS). The blood pressure effect
was thus due primarily to changes in total peripheral resistance
(%LTPR, cool +26 13.6, warm +8.6 14.5, P < 0.02). Based
on a two factor repeated measures ANOVA design assessing time
and treatment effect, a time X treatment interaction was present
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Fig. 2. Hemodynamic study: Results of hourly measurements of tympanic
membrane temperature during cool (0) versus warm (S) dialysis. The
differences in body temperatures assessed in this manner were highly
significant.
for diastolic and mean blood pressure (P 0.035 and 0.022,
respectively). There was no time X treatment interaction for
cardiac output (P = 0.805), and a borderline significant (P = 0.08)
time x treatment interaction for TPR. These hemodynamic
indices, including changes in heart rate, are summarized in Figure
1. The change in tympanic membrane temperature as a result of
cool dialysate use —0.51 0.23°C was significantly different from
that during warm dialysate +0.52 0.14°C, P < 0.001. Hourly
changes in tympanic membrane temperature are shown in Figure
2.
Single pool urea KtIV, derived from the 15 second post-dialysis
SUN, was similar with the cool and warm treatments: 1.25 0.14
and 1.38 0.10 Kt/V units, respectively; P = NS. Total urea
recovered in the spent dialysate normalized to the predialysis
SUN concentration also was comparable (cool 31.3 3.9 liter1,
warm 29.7 2.1; P = NS), suggesting that cool dialysate use had
neither an adverse or beneficial effect on urea removal.
Detailed urea kinetic study
Blood pressure results. The blood pressure differences between
the cool and warm dialysis treatments in this study are shown in
Figures 3 and 4, this time in terms of systolic and diastolic blood
pressures. The magnitude of the blood pressure difference was
quite similar to that found in the hemodynamic study. Treatment
effects or a time X treatment interaction were present by two
factor repeated measures ANOVA for both systolic (P = 0.008)
and diastolic (P = 0.023) blood pressures. Again, there was no
significant difference in the amount of fluid removed between the
two treatments.
Dialyzer urea clearance measurements. During cool dialysis,
mean urea clearance, based on measurements taken 30 minutes
into dialysis, was 225 4.0 ml/min. During warm dialysis, dialyzer
clearance averaged 230 2.9 ml/min. These values were not
significantly different.
Intradialytic and postdialysis SUN results. The mean levels of
SUN for the two treatments are presented in Figure 5. For ease of
comparison, all values are normalized to the predialysis SUN
(cool 56.2 3.2 mg/dl, warm 50.0 12.6; P = NS). As evident
from the Figure, there was no difference in intradialytic urea
profile between the warm and cool dialysate treatments. The
postdialysis SUN rebound values between 15 seconds and 30
minutes were not significantly different between the two dialy-
sates, whether rebound was computed as a % of the post-SUN
value, or as a % of the fall in SUN. These results are shown in
Figure 6.
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Fig. 1. 1-Jemodynamic study: Hemodynamic
indices including MAP, cardiac index (CI), TPR,
and heart rate (HR) during cool (0) and warm
(S) dialysis. Only changes in MAP and TPR
were statistically significant.
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Fig. 3. Urea kinetic study: Systolic blood pressure during dialysis with cool
(0) and warm (•) dialysate. By repeated measures ANOVA, the blood
pressures are significantly different between the two treatments (P < 0.01).
Asterisks identify significance levels at each individual time point by
paired t-testing.
25
20
15
10
5
0
—5
—10
—15
—20
—25
0 1
Time, hours
Fig. 4. Urea kinetic study: Diastolic blood pressure during dialysis with cool
(0) and warm (S) dialysate. By repeated measures ANOVA, the blood
pressures are significantly different between the two treatments (P < 0.02).
Asterisks identify significance levels at each individual time point by
paired t-testing. Points marked by (+) signs are significant using a
one-tailed test only.
Access recirculation
The mean ratio of the 30 minutes and post-dialysis urea
concentrations to the values in specimens drawn 15 seconds later
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Fig. 5. Urea kinetic study: Serum urea nitrogen (SUN) values for cool and
warm dialysis, with the data expressed as a fraction of the predialysis SUN level.
There was no significant treatment difference for either the intradialytic or
postdialytic SUN profile by two-factor repeated measures ANOVA.
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Fig. 6. Urea kinetic study: Postdialysis urea rebound, using the 15 second
post-dialysis value, expressed by two different methods. In one method
(circles), rebound was expressed as percent increase above the 15-sec post
concentration. In another method (squares), rebound was computed as a
fraction of the decrease in SUN during dialysis: 100 X (rebound value —
15 second post-value)/(pre-value — 15 second post-value). Rebound was
corrected for urea generation. There was no significant treatment effect of
either rebound profile by two factor repeated measures ANOVA.
after slowing the pump to 50 ml/min was 1.0, and the ratio was
always greater than 0.92, strongly suggesting that, in these studies,
given the coefficient of variation for urea measurements, signifi-
cant access recirculation was not present (when the outlet to inlet
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Fig. 7. Urea kinetic study: Three blood-side derived Kt/V measures and one
dialysate-side Kt/V measure are shown for both cool (hollow bars) and warm
(hatched bars) dialysate. The blood-sided Kt/V values were computed
based on post-dialysis SUN values taken at 15 seconds, 2 minutes, and 30
minutes post-dialysis, corrected for g. In none of the comparisons was
there a significant difference between cool and warm dialysate; in fact, the
trend was for a slightly higher KtIV with use of cool dialysate.
ratio is 0.3, an access recirculation of 14% translated into a ratio
of 0.90). Also, the ratio of the SUN values in these specimens to
those taken two minutes later after slowing the blood pump to 50
mi/mm averaged 0.95, the expected values for the AIV SUN ratio
under these dialysis conditions and was never less than 0.91, again,
militating against the presence of vascular access recirculation in
any of the studies. Computed in the standard fashion [100 x
(S-I)I(S-O)] 30 minutes after dialysis, access recirculation for cool
dialysate averaged —1.8 3.5%, maximum 9.7%, and for warm
dialysate averaged —4.5 6.2%, maximum 8.7%.
Blood-sided urea modeling results
Kt/V based on 15 seconds post- or two minutes post-dialysis
SUN measurements was calculated using a two-point variable-
volume single pooi urea kinetic model [27], and also using the
Daugirdas 2nd generation estimation [28]. "Equilibrated" KtIV
also was computed based on the 30-minute post-dialysis SUN
reduced appropriately for urea generation during the 30-minute
post-dialysis rebound period. As evident from Figure 7, there was
no difference in either standard single-pool Kt/V or in the
"equilibrated" Kt/V between the two treatments. As expected, the
"equilibrated" KtIV (30 mm) was lower than the single-pool Kt/V
(15 seconds), by 9.43% 1.06 in the cool dialysate treatments,
and by 10.3% 1.8% in the warm studies, P = NS between the
two treatments. Based on two-minute post-dialysis samples and
single-pool urea kinetics (including multiplication of Kd by the
ratio of the 0 to 2 minute post-dialysis sample to correct Kd of A/V
gradient), the modeled V was 37.3 2.1 for the cool dialysate
treatments, and 40.1 2.6 liter for the warm studies, P = NS
between the two. K/V values for the cool and warm studies were
5.38 0.31 ml/min/liter and 5.12 0.29 mi/mm/liter, respectively.
Dialysate modeling results
Based on total dialysate recovery, the total urea removed
normalized to predialysis SUN was again similar in the cool (31.1
2.5 liter) and warm (28.6 1.4 iiter1) treatments, P = NS.
The same values calculated based on Biostat-1000 derived total
urea removal were quite similar, although about 10% higher (cool
35.1 2.7 iiter', warm 33.0 1.8; P = NS). The slight shortfall
in dialysate urea recovery with the total collection method may
have been due to incomplete mixing of the spent dialysate in the
large collection tank, or else to differences in assay procedures for
urea used with the two methods. Total urea recovered by dialysate
collection correlated highly with that estimated by the Biostat-
1000 device (cool r = 0.96, warm r = 0.85). The Biostat-1000 also
can derive a dialysate-based KtIV value that is an "equilibrated"
Kt/V and generally similar to that obtained using a 30-minute
post-dialysis rebound sample [25]. This dialysate-side "equilibrat-
ed" Kt/V was 1.26 0.07 for those studies in which cool dialysate
was used, and 1.21 0.08 for the warm studies. Again, there was
no difference between cool and warm dialysate use.
Discussion
In our study, moderate cooling of the dialysate to 35°C was
associated with an increased mean arterial pressure as reported
previously by many other authors [1—8]. We extended previous
observations by measuring bioimpedance-derived cardiac output,
which suggested that the blood pressure difference between cool
and warm dialysate use could be accounted for entirely by
differences in total peripheral vascular resistance (TPR), confirm-
ing our previous finding in dogs [3]. Our observation is consistent
with data by Jost and colleagues in humans, that cool dialysate
results in increased vascular resistance in the lower leg as mea-
sured by plethysmography [8]. The magnitude of the difference in
TPR was not large, on the order of 20%, suggesting that it might
be accounted for largely or entirely by changes in skin blood flow.
Use of cool dialysate had no effect on the compartmentalization
of urea during dialysis. There was no effect on the magnitude of
post-dialysis urea rebound, and no effect on the amount of urea
recovered from spent dialysate. How can one explain the negative
results of this study and still support a regional blood flow model
[18, 19] of urea kinetics? The key question is not what happens to
total cardiac output, or to total peripheral vascular resistance, but
what happens to the regional distribution of blood flow. Certainly
regional blood flow can be markedly altered with little change in
cardiac output or TPR [29]. Of the three organs (muscle, skin, and
bone) that contain most of the total body water and hence urea,
muscle is by far the most important. For example, muscle alone
should contain about 55% of the total body urea [19]. During the
mild cold stress imposed by use of cool dialysate, calf vascular
resistance has been shown to increase [8]. It is possible that the
increase in vascular resistance found during use of cool dialysate
may be focused primarily on the cutaneous circulation. Perhaps
actual blood flow to muscle decreases only slightly, if at all. Based
on pathologic data, the skin contains only 10 to 15% of the total
body water (and hence urea). Thus, increased sequestration of
urea in the skin during dialysis should, of itself have little impact
on total urea compartmentalization or extraction. To the contrary,
use of cool dialysate may actually help maintain blood flow by
maintaining blood pressure. Normally there is tonic inhibition of
sympathetic outflow. A fall in MAP during dialysis can activate
baroreceptors and disinhibit sympathetic outflow, Sympathetic
outflow increases vascular resistance primarily to cutaneous,
renal, and muscle circulations [20]. Thus, one scenario regarding
muscle blood flow with warm versus cool dialysate might play as
follows:
1.5
1.4
1.3
1.2
Kt/V 15 seconds KtN 2 minutes KtN 30 minutes KtN Biostat
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Warm. Volume depletion — fall in MAP — baroreceptor
activation — fall in muscle blood flow —p increased urea compart-
mentalization
Cool. Volume depletion + cutaneous vasoconstriction — no
fall in MAP —p little baroreceptor activation —+ little change in
muscle blood flow —+ no change in urea compartmentalization
Conceivably, cool dialysate use might augment venous tone
during hemodialysis. Augmented venous tone may limit seques-
tration of blood in veins and thus help preserve cardiac filling [201.
However, in our hemodynamic study there was no difference in
cardiac output during cool versus warm dialysis.
How can our results be reconciled with those of Depner et al,
who measured end-dialysis urea concentration and post-dialysis
urea rebound in access blood and opposite arm cutaneous vein
blood [301? Depner and colleagues found that, at the end of
dialysis when cool dialysate was used, there was a marked
difference between arterial blood (as represented by access blood
drawn while the access segment between the two dialysis needles
was occluded) and opposite arm cutaneous blood (the latter being
higher). The difference increased as dialysis progressed. When
dialysis was performed using a 'hot' dialysate (39°C), the arterial!
cutaneous vein difference in urea concentration all but disap-
peared. The results were interpreted to suggest that dialysate
temperature affected the degree of urea compartmentalization.
However, in Depner et al's study, cool versus 'hot' and not cool
versus warm dialysates were being compared. The heat stress
associated with use of the hot dialysate probably caused a marked
increase in cutaneous blood flow with opening of cutaneous
arteriovenous shunts [31, 321. Thus, in Depner et al's study with
'hot' dialysate, there may have been some arterialization of blood
in the opposite arm cutaneous venous sample, which may have
partially obliterated the expected difference between venous and
arterial blood that should have been present due to dialysis [331.
In Depner et al's study, the total post-dialysis urea rebound was
significantly lower after 'hot' dialysis compared to after use of
'cool' dialysate. The apparent reduction in the degree of urea
compartmentalization associated with use of 'hot' dialysate may
have been due to increased cardiac output and perhaps increased
muscle flow due to the associated heat stress [31, 321.
In summary, our findings suggest that the increased blood
pressure associated with cool dialysis is due largely, if not com-
pletely, to an increased TPR. The hemodynamic changes associ-
ated with use of cool dialysate are not associated with increased
urea compartmentalization and do not impair urea removal,
probably because blood flow alterations are largely confined to
the skin, and possibly because a higher level of mean arterial
pressure may actually help maintain muscle blood flow. Lowering
the dialysate temperature to 35°C can be done without fear of
reducing overall dialysis efficiency.
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